Literature DB >> 11807411

Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples.

K V Chowdari1, B Brandstaetter, P Semwal, T Bhatia, S Deshpande, R Reddy, J Wood, C R Weinberg, B K Thelma, V L Nimgaonkar.   

Abstract

An association between the cytosolic phospholipase A2 locus (cPLA2) and schizophrenia has been reported using two polymorphic DNA markers. In an attempt to replicate these results, two independent family-based samples were ascertained from the United States and India (86 and 159 families, respectively). No significant associations were detected in either sample.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11807411      PMCID： PMC5466560          DOI： 10.1097/00041444-200112000-00005

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN： 0955-8829            Impact factor:   2.458


  29 in total

1.  Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia.

Authors:  M S Keshavan; J W Pettegrew; K S Panchalingam; D Kaplan; E Bozik
Journal:  Arch Gen Psychiatry       Date:  1991-12

2.  Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

Authors:  J W Pettegrew; M S Keshavan; K Panchalingam; S Strychor; D B Kaplan; M G Tretta; M Allen
Journal:  Arch Gen Psychiatry       Date:  1991-06

3.  A Hindi version of the Diagnostic Interview for Genetic Studies.

Authors:  S N Deshpande; M N Mathur; S K Das; T Bhatia; S Sharma; V L Nimgaonkar
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

4.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

5.  Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: the relationship between dyslexia and schizophrenia.

Authors:  D F Horrobin; A I Glen; C J Hudson
Journal:  Med Hypotheses       Date:  1995-12       Impact factor: 1.538

6.  Increased serum phospholipase A2 activity in schizophrenia: a replication study.

Authors:  W F Gattaz; C V Hübner; T J Nevalainen; T Thuren; P K Kinnunen
Journal:  Biol Psychiatry       Date:  1990-09-15       Impact factor: 13.382

7.  The transmission/disequilibrium test detects cosegregation and linkage.

Authors:  R S Spielman; R E McGinnis; W J Ewens
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

8.  Increased platelet phospholipase A2 activity in schizophrenia.

Authors:  W F Gattaz; A Schmitt; A Maras
Journal:  Schizophr Res       Date:  1995-07       Impact factor: 4.939

9.  Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.

Authors:  W F Gattaz; M Köllisch; T Thuren; J A Virtanen; P K Kinnunen
Journal:  Biol Psychiatry       Date:  1987-04       Impact factor: 13.382

Review 10.  The membrane hypothesis of schizophrenia.

Authors:  D F Horrobin; A I Glen; K Vaddadi
Journal:  Schizophr Res       Date:  1994-10       Impact factor: 4.939
View more
  10 in total

1.  Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study.

Authors:  Prachi Semwal; Suman Prasad; Panchami G Varma; A M Bhagwat; S N Deshpande; B K Thelma
Journal:  J Genet       Date:  2002-08       Impact factor: 1.166

Review 2.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

3.  cPLA2 is protective against COX inhibitor-induced intestinal damage.

Authors:  David C Montrose; Krishna Kadaveru; Jillian N M Ilsley; Sierra H Root; Thiruchanduri V Rajan; Manish Ramesh; Frank C Nichols; Bruce T Liang; Dmitry Sonin; Arthur R Hand; Simona Zarini; Robert C Murphy; Glenn S Belinsky; Masako Nakanishi; Daniel W Rosenberg
Journal:  Toxicol Sci       Date:  2010-06-18       Impact factor: 4.849

Review 4.  Molecular genetics of schizophrenia: past, present and future.

Authors:  Suman Prasad; Prachi Semwal; Smita Deshpande; Triptish Bhatia; V L Nimgaonkar; B K Thelma
Journal:  J Biosci       Date:  2002-02       Impact factor: 1.826

5.  Association between BanI genotype and increased phospholipase A2 activity in schizophrenia.

Authors:  Nadia R Barbosa; Ricardo M Junqueira; Homero P Vallada; Wagner F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-07-14       Impact factor: 5.270

6.  Re-analysis of genetic polymorphism data supports a relationship between schizophrenia and microsatellite variability in PLA2G4A.

Authors:  Craig J Hudson; Justin X G Zhu; Alexandra M Durocher
Journal:  Psychiatr Genet       Date:  2021-06-01       Impact factor: 2.458

7.  Molecular biology research in neuropsychiatry: India's contribution.

Authors:  T S Sathyanarayana Rao; B N Ramesh; P Vasudevaraju; K S J Rao
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

8.  Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China.

Authors:  Guang Yang; Hongqin Xu; Huiping Zhang; Qiong Yu; Yanhua Wu; Jieping Shi; Wenwang Rao; Yueyue You; Changgui Kou; Yaqin Yu
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

Review 9.  Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia.

Authors:  Sabrina H Ansarey
Journal:  Front Psychiatry       Date:  2021-11-30       Impact factor: 4.157

10.  Genetic polymorphism data support a relationship between schizophrenia and microsatellite variability in PLA2G4A in Northern Europeans not Han Chinese.

Authors:  Craig J Hudson; Adam M R Groh; Fabio Macciardi; Rhys C Hudson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2021-12-09       Impact factor: 3.358
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.